docetaxel loaded peg-plga nanoparticles: optimized drug loading, in vitro cytotoxicity and in vivo antitumor effect

Authors

mona noori koopaei tehran university of medical sciences

mohammad reza khoshayand tehran university of medical sciences

seyed hossein mostafavi tehran university of medical sciences

mohsen amini tehran university of medical sciences

abstract

in this study a 3-factor, 3-level box-behnken design was used to prepare optimized docetaxel (dtx) loaded pegylated poly lactide-co-glycolide (peg-plga) nps with polymer concentration (x1), drug concentration (x2) and ratio of the organic to aqueous solvent (x3) as the independent variables and particle size (y1), poly dispersity index (pdi) (y2) and drug loading (y3) as the responses. the cytotoxicity of optimized dtx loaded peg-plga nps was studied in skov3 tumor cell lines by standard mtt assay. the in vivo antitumor efficacy of dtx loaded plga-peg nps was assessed in tumor bearing female balb/c mice. the optimum level of y1, y2 and y3 predicted by the model were 188 nm, 0.16 and 9% respectively with perfect agreement with the experimental data. the in vitro release profile of optimum formulation showed a burst release of approximately 20% (w/w) followed by a sustained release profile of the loaded drug over 288 h. the dtx loaded optimized nanoparticles showed a greater cytotoxicity against skov3 cancer cells than free dtx. enhanced tumor-suppression effects were achieved with dtx-loaded peg-plga nps. these results demonstrated that optimized nps could be a potentially useful delivery system for dtx as an anticancer agent.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Docetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in vitro cytotoxicity and in vivo antitumor effect

In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) loaded pegylated poly lactide-co-glycolide (PEG-PLGA) NPs with polymer concentration (X1), drug concentration (X2) and ratio of the organic to aqueous solvent (X3) as the independent variables and particle size (Y1), poly dispersity index (PDI) (Y2) and drug loading (Y3) as the responses. The cyto...

full text

Docetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in vitro cytotoxicity and in vivo antitumor effect

In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) loaded pegylated poly lactide-co-glycolide (PEG-PLGA) NPs with polymer concentration (X1), drug concentration (X2) and ratio of the organic to aqueous solvent (X3) as the independent variables and particle size (Y1), poly dispersity index (PDI) (Y2) and drug loading (Y3) as the responses. The cyto...

full text

Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect

In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) loaded pegylated poly lactide-co-glycolide (PEG-PLGA) Nanoparticles (NPs) with polymer concentration (X1), drug concentration (X2) and ratio of the organic to aqueous solvent (X3) as the independent variables and particle size (Y1), poly dispersity index (PDI) (Y2) and drug loading (Y3) as the res...

full text

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation

Endostar, a novel recombinant human endostatin, which was approved by the Chinese State Food and Drug Administration in 2005, has a broad spectrum of activity against solid tumors. In this study, we aimed to determine whether the anticancer effect of Endostar is increased by using a nanocarrier system. It is expected that the prolonged circulation of endostar will improve its anticancer activit...

full text

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile

Docetaxel is a highly potent anticancer agent being used in a wide spectrum of cancer types. There are important matters of concern regarding the drug's pharmacokinetics related to the conventional formulation. Poly(lactide-co-glycolide) (PLGA) is a biocompatible/biodegradable polymer with variable physicochemical characteristics, and its application in human has been approved by the United Sta...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pharmaceutical research

جلد ۱۳، شماره ۳، صفحات ۸۱۹-۸۳۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023